<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>954</ReferenceId>
        <DateLastUpdated>2011-02-01-08:00</DateLastUpdated>
        <Article>
            <PubmedId>12183547</PubmedId>
            <Abstract>Guillain-Barré syndrome following Campylobacter jejuni infection is frequently associated with anti-ganglioside autoantibodies mediated by molecular mimicry with ganglioside-like oligosaccharides on bacterial lipopolysaccharide (LPS). The regulation of antibody responses to these T-cell-independent antigens is poorly understood, and only a minority of Campylobacter-infected individuals develop anti-ganglioside antibodies. This study investigates the response to gangliosides and LPS in strains of mice by using a range of immunization strategies. In normal mice following intraperitoneal immunization, antibody responses to gangliosides and LPS are low level but can be enhanced by the antigen format or coadministration of protein to recruit T-cell help. Class switching from the predominant immunoglobulin M (IgM) response to IgG3 occurs at low levels, suggesting B1-cell involvement. Systemic immunization results in poor responses. In GalNAc transferase knockout mice that lack all complex gangliosides and instead express high levels of GM3 and GD3, generation of anti-ganglioside antibodies upon immunization with either complex gangliosides or ganglioside-mimicking LPS is greatly enhanced and exhibits class switching to T-cell-dependent IgG isotypes and immunological memory, indicating that tolerance to self gangliosides is a major regulatory factor. Responses to GD3 are suppressed in knockout mice compared with wild-type mice, in which responses to GD3 are induced specifically by GD3 and as a result of polyclonal B-cell activation by LPS. The anti-ganglioside response generated in response to LPS is also dependent on the epitope density of the ganglioside mimicked and can be further manipulated by providing secondary signals via lipid A and CD40 ligation.</Abstract>
            <ArticleYear>2002</ArticleYear>
            <ArticlePages>5008-18</ArticlePages>
            <ArticleTitle>Tolerance to self gangliosides is the major factor restricting the antibody response to lipopolysaccharide core oligosaccharides in Campylobacter jejuni strains associated with Guillain-Barré syndrome.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Bowes</LastName>
                    <ForeName>Tyrone</ForeName>
                </Author>
                <Author>
                    <LastName>Wagner</LastName>
                    <ForeName>Eric R</ForeName>
                </Author>
                <Author>
                    <LastName>Boffey</LastName>
                    <ForeName>Judith</ForeName>
                </Author>
                <Author>
                    <LastName>Nicholl</LastName>
                    <ForeName>Dawn</ForeName>
                </Author>
                <Author>
                    <LastName>Cochrane</LastName>
                    <ForeName>Lynne</ForeName>
                </Author>
                <Author>
                    <LastName>Benboubetra</LastName>
                    <ForeName>Mustapha</ForeName>
                </Author>
                <Author>
                    <LastName>Conner</LastName>
                    <ForeName>Joe</ForeName>
                </Author>
                <Author>
                    <LastName>Furukawa</LastName>
                    <ForeName>Keiko</ForeName>
                </Author>
                <Author>
                    <LastName>Furukawa</LastName>
                    <ForeName>Koichi</ForeName>
                </Author>
                <Author>
                    <LastName>Willison</LastName>
                    <ForeName>Hugh J</ForeName>
                </Author>
            </Authors>
            <Affiliations>University Department of Neurology, Institute of Neurological Sciences, Southern General Hospital, Glasgow, Scotland G51 4TF.</Affiliations>
            <ArticleChemicalList>Antibodies, Bacterial;Antigens, CD40;Autoantibodies;Gangliosides;Lipopolysaccharides;Liposomes;lipid-linked oligosaccharides;N-Acetylgalactosaminyltransferases;(N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase</ArticleChemicalList>
            <ArticleMeshHeadingsList>Animals; Antibodies, Bacterial(biosynthesis ); Antigens, CD40(metabolism ); Autoantibodies(biosynthesis ); Campylobacter Infections(complications; immunology ); Campylobacter jejuni(immunology; pathogenicity ); Carbohydrate Sequence; Female; Gangliosides(chemistry; immunology ); Guillain-Barre Syndrome(etiology; immunology ); Humans; Immunization; Lipopolysaccharides(chemistry; immunology ); Liposomes; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Knockout; Molecular Mimicry; Molecular Sequence Data; N-Acetylgalactosaminyltransferases(deficiency; genetics ); Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Self Tolerance </ArticleMeshHeadingsList>
            <Journal>
                <Volume>70</Volume>
                <Issue>9</Issue>
                <Title>Infection and immunity</Title>
                <Issn>1098-5522</Issn>
                <MedlineTa>Infect Immun</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>GM1 carbohydrate epitope</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalNonSequenceMolecule>
                        <ChemicalType>Carbohydrate fragment</ChemicalType>
                        <Molecule>
                            <ChEBIId>CHEBI:59208</ChEBIId>
                        </Molecule>
                        <SourceMolecule>
                            <ChEBIId>CHEBI:18216</ChEBIId>
                        </SourceMolecule>
                        <SourceOrganismId>7742</SourceOrganismId>
                    </FragmentOfANaturalNonSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 1</LocationOfData>
                <EpitopeId>130678</EpitopeId>
                <EpitopeEvidenceCode>Exact match to reference information</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The epitope is deduced to be the carbohydrate moiety from the lack of cross-reactivity towards other gangliosides.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Figures 2 and 3</LocationOfData>
                        <BCellId>11689</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                                <Age>6-8 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Structurally Related</EpitopeRelation>
                                    <Object>
                                        <AccessionNonSequenceMolecule>
                                            <ChemicalType>Glycolipid</ChemicalType>
                                            <Molecule>
                                                <ChEBIId>CHEBI:27515</ChEBIId>
                                            </Molecule>
                                            <SourceOrganismId>7742</SourceOrganismId>
                                        </AccessionNonSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Ganglioside GQ1b</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                                <Route>Intraperitoneal (i.p.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Mice were primed with 60 μg ovalbumin in alum and then immunized 7-10 days later via the i.p. route with an ovalbumin-liposome formulation containing 100μg ganglioside per mouse. Subsequent immunizations were administered at 2-week intervals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>IgM responses were not significantly cross-reactive between the immunogen and antigen gangliosides.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgM</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>GM1 ganglioside commercial preparation</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionNonSequenceMolecule>
                                        <ChemicalType>Other Non-Sequence</ChemicalType>
                                        <Molecule>
                                            <ChEBIId>CHEBI:18216</ChEBIId>
                                        </Molecule>
                                        <SourceOrganismId>7742</SourceOrganismId>
                                    </AccessionNonSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 3A</LocationOfData>
                        <BCellId>17688</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000006</OrganismId>
                                <Age>6-8 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Structurally Related</EpitopeRelation>
                                    <Object>
                                        <AccessionNonSequenceMolecule>
                                            <ChemicalType>Glycolipid</ChemicalType>
                                            <Molecule>
                                                <ChEBIId>CHEBI:18163</ChEBIId>
                                            </Molecule>
                                            <SourceOrganismId>7742</SourceOrganismId>
                                        </AccessionNonSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Ganglioside GD1a</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                                <Route>Intraperitoneal (i.p.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Mice were primed with 60 μg ovalbumin in alum and then immunized 7-10 days later via the i.p. route with an ovalbumin-liposome formulation containing 100 μg ganglioside per mouse. Subsequent immunizations were administered at 2-week intervals. GalNAcT-/- mice possess only GM3 and GD3 gangliosides, lacking GD1a, GT1a, GQ1b, and GM1 gangliosides.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>IgM responses were not significantly cross-reactive between the immunogen and antigen gangliosides.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgM</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>GM1 ganglioside commercial preparation</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionNonSequenceMolecule>
                                        <ChemicalType>Other Non-Sequence</ChemicalType>
                                        <Molecule>
                                            <ChEBIId>CHEBI:18216</ChEBIId>
                                        </Molecule>
                                        <SourceOrganismId>7742</SourceOrganismId>
                                    </AccessionNonSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 5B</LocationOfData>
                        <BCellId>1803969</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000006</OrganismId>
                                <Age>6-8 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Structurally Related</EpitopeRelation>
                                    <Object>
                                        <AccessionNonSequenceMolecule>
                                            <ChemicalType>Glycolipid</ChemicalType>
                                            <Molecule>
                                                <ChEBIId>CHEBI:35371</ChEBIId>
                                            </Molecule>
                                            <SourceOrganismId>10000716</SourceOrganismId>
                                        </AccessionNonSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>C. jejuni HS:19 LPS</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Route>Intraperitoneal (i.p.)</Route>
                                <DoseSchedule>Mice were primed with 100 μg LPS in 100-μl CFA and boosted in IFA at 2 week intervals.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>GalNAcT-/- mice possess only GM3 and GD3 gangliosides, lacking GD1a, GT1a, GQ1b, and GM1 gangliosides.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>IgG responses in GaltT-/- mice were cross-reactive between the LPS immunogen and the ganglioside antigen.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>GM1 ganglioside commercial preparation</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionNonSequenceMolecule>
                                        <ChemicalType>Other Non-Sequence</ChemicalType>
                                        <Molecule>
                                            <ChEBIId>CHEBI:18216</ChEBIId>
                                        </Molecule>
                                        <SourceOrganismId>7742</SourceOrganismId>
                                    </AccessionNonSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <BCellId>1803966</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000006</OrganismId>
                                <Age>6-8 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Structurally Related</EpitopeRelation>
                                    <Object>
                                        <AccessionNonSequenceMolecule>
                                            <ChemicalType>Glycolipid</ChemicalType>
                                            <Molecule>
                                                <ChEBIId>CHEBI:28424</ChEBIId>
                                            </Molecule>
                                            <SourceOrganismId>7742</SourceOrganismId>
                                        </AccessionNonSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Ganglioside GD3</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                                <Route>Intraperitoneal (i.p.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Mice were primed with 60 μg ovalbumin in alum and then immunized 7-10 days later via the i.p. route with an ovalbumin-liposome formulation containing 100 μg ganglioside per mouse. Subsequent immunizations were administered at 2-week intervals. GalNAcT-/- mice possess only GM3 and GD3 gangliosides, lacking GD1a, GT1a, GQ1b, and GM1 gangliosides.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>IgG responses were not significantly cross-reactive between the LPS immunogen and the ganglioside antigen.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>GM1 ganglioside commercial preparation</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionNonSequenceMolecule>
                                        <ChemicalType>Other Non-Sequence</ChemicalType>
                                        <Molecule>
                                            <ChEBIId>CHEBI:18216</ChEBIId>
                                        </Molecule>
                                        <SourceOrganismId>7742</SourceOrganismId>
                                    </AccessionNonSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <BCellId>1803967</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                                <Age>6-8 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Structurally Related</EpitopeRelation>
                                    <Object>
                                        <AccessionNonSequenceMolecule>
                                            <ChemicalType>Glycolipid</ChemicalType>
                                            <Molecule>
                                                <ChEBIId>CHEBI:28424</ChEBIId>
                                            </Molecule>
                                            <SourceOrganismId>7742</SourceOrganismId>
                                        </AccessionNonSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Ganglioside GD3</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                                <Route>Intraperitoneal (i.p.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Mice were primed with 60 μg ovalbumin in alum and then immunized 7-10 days later via the i.p. route with an ovalbumin-liposome formulation containing 100μg ganglioside per mouse. Subsequent immunizations were administered at 2-week intervals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>IgG responses were not significantly cross-reactive between the LPS immunogen and the ganglioside antigen.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>GM1 ganglioside commercial preparation</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionNonSequenceMolecule>
                                        <ChemicalType>Other Non-Sequence</ChemicalType>
                                        <Molecule>
                                            <ChEBIId>CHEBI:18216</ChEBIId>
                                        </Molecule>
                                        <SourceOrganismId>7742</SourceOrganismId>
                                    </AccessionNonSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 5A</LocationOfData>
                        <BCellId>1803968</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000006</OrganismId>
                                <Age>6-8 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Structurally Related</EpitopeRelation>
                                    <Object>
                                        <AccessionNonSequenceMolecule>
                                            <ChemicalType>Glycolipid</ChemicalType>
                                            <Molecule>
                                                <ChEBIId>CHEBI:35371</ChEBIId>
                                            </Molecule>
                                            <SourceOrganismId>10000717</SourceOrganismId>
                                        </AccessionNonSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>C. jejuni HS:4 LPS</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Route>Intraperitoneal (i.p.)</Route>
                                <DoseSchedule>Mice were primed with 100 μg LPS in 100-μl CFA and boosted in IFA at 2 week intervals.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>GalNAcT-/- mice possess only GM3 and GD3 gangliosides, lacking GD1a, GT1a, GQ1b, and GM1 gangliosides.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>IgG responses were not significantly cross-reactive between the LPS immunogen and the ganglioside antigen.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>anti-GM1 ganglioside Ab</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>GM1 ganglioside commercial preparation</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionNonSequenceMolecule>
                                        <ChemicalType>Other Non-Sequence</ChemicalType>
                                        <Molecule>
                                            <ChEBIId>CHEBI:18216</ChEBIId>
                                        </Molecule>
                                        <SourceOrganismId>7742</SourceOrganismId>
                                    </AccessionNonSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 5A</LocationOfData>
                        <BCellId>1803970</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                                <Age>6-8 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Structurally Related</EpitopeRelation>
                                    <Object>
                                        <AccessionNonSequenceMolecule>
                                            <ChemicalType>Glycolipid</ChemicalType>
                                            <Molecule>
                                                <ChEBIId>CHEBI:35371</ChEBIId>
                                            </Molecule>
                                            <SourceOrganismId>10000717</SourceOrganismId>
                                        </AccessionNonSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>C. jejuni HS:4 LPS</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Route>Intraperitoneal (i.p.)</Route>
                                <DoseSchedule>Mice were primed with 100 μg LPS in 100-μl CFA and boosted in IFA at 2 week intervals.</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>IgG responses were not significantly cross-reactive between the LPS immunogen and the ganglioside antigen.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>GM1 ganglioside commercial preparation</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionNonSequenceMolecule>
                                        <ChemicalType>Other Non-Sequence</ChemicalType>
                                        <Molecule>
                                            <ChEBIId>CHEBI:18216</ChEBIId>
                                        </Molecule>
                                        <SourceOrganismId>7742</SourceOrganismId>
                                    </AccessionNonSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 3A</LocationOfData>
                        <BCellId>1803964</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000006</OrganismId>
                                <Age>6-8 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Structurally Related</EpitopeRelation>
                                    <Object>
                                        <AccessionNonSequenceMolecule>
                                            <ChemicalType>Glycolipid</ChemicalType>
                                            <Molecule>
                                                <ChEBIId>CHEBI:18163</ChEBIId>
                                            </Molecule>
                                            <SourceOrganismId>7742</SourceOrganismId>
                                        </AccessionNonSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Ganglioside GD1a</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                                <Route>Intraperitoneal (i.p.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Mice were primed with 60 μg ovalbumin in alum and then immunized 7-10 days later via the i.p. route with an ovalbumin-liposome formulation containing 100 μg ganglioside per mouse. Subsequent immunizations were administered at 2-week intervals. GalNAcT-/- mice possess only GM3 and GD3 gangliosides, lacking GD1a, GT1a, GQ1b, and GM1 gangliosides.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>IgG responses were not significantly cross-reactive between the LPS immunogen and the ganglioside antigen.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>GM1 ganglioside commercial preparation</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionNonSequenceMolecule>
                                        <ChemicalType>Other Non-Sequence</ChemicalType>
                                        <Molecule>
                                            <ChEBIId>CHEBI:18216</ChEBIId>
                                        </Molecule>
                                        <SourceOrganismId>7742</SourceOrganismId>
                                    </AccessionNonSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 5B</LocationOfData>
                        <BCellId>1803971</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                                <Age>6-8 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Structurally Related</EpitopeRelation>
                                    <Object>
                                        <AccessionNonSequenceMolecule>
                                            <ChemicalType>Glycolipid</ChemicalType>
                                            <Molecule>
                                                <ChEBIId>CHEBI:35371</ChEBIId>
                                            </Molecule>
                                            <SourceOrganismId>10000716</SourceOrganismId>
                                        </AccessionNonSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>C. jejuni HS:19 LPS</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Route>Intraperitoneal (i.p.)</Route>
                                <DoseSchedule>Mice were primed with 100 μg LPS in 100-μl CFA and boosted in IFA at 2 week intervals.</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>IgG responses were not significantly cross-reactive between the LPS immunogen and the ganglioside antigen.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>GM1 ganglioside commercial preparation</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionNonSequenceMolecule>
                                        <ChemicalType>Other Non-Sequence</ChemicalType>
                                        <Molecule>
                                            <ChEBIId>CHEBI:18216</ChEBIId>
                                        </Molecule>
                                        <SourceOrganismId>7742</SourceOrganismId>
                                    </AccessionNonSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figures 2 and 3</LocationOfData>
                        <BCellId>1803963</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                                <Age>6-8 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Structurally Related</EpitopeRelation>
                                    <Object>
                                        <AccessionNonSequenceMolecule>
                                            <ChemicalType>Glycolipid</ChemicalType>
                                            <Molecule>
                                                <ChEBIId>CHEBI:27515</ChEBIId>
                                            </Molecule>
                                            <SourceOrganismId>7742</SourceOrganismId>
                                        </AccessionNonSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Ganglioside GQ1b</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                                <Route>Intraperitoneal (i.p.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Mice were primed with 60 μg ovalbumin in alum and then immunized 7-10 days later via the i.p. route with an ovalbumin-liposome formulation containing 100μg ganglioside per mouse. Subsequent immunizations were administered at 2-week intervals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>IgG responses were not significantly cross-reactive between the LPS immunogen and the ganglioside antigen.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>GM1 ganglioside commercial preparation</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionNonSequenceMolecule>
                                        <ChemicalType>Other Non-Sequence</ChemicalType>
                                        <Molecule>
                                            <ChEBIId>CHEBI:18216</ChEBIId>
                                        </Molecule>
                                        <SourceOrganismId>7742</SourceOrganismId>
                                    </AccessionNonSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 3B</LocationOfData>
                        <BCellId>1803965</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000006</OrganismId>
                                <Age>6-8 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Structurally Related</EpitopeRelation>
                                    <Object>
                                        <AccessionNonSequenceMolecule>
                                            <ChemicalType>Glycolipid</ChemicalType>
                                            <Molecule>
                                                <ChEBIId>CHEBI:27515</ChEBIId>
                                            </Molecule>
                                            <SourceOrganismId>7742</SourceOrganismId>
                                        </AccessionNonSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Ganglioside GQ1b</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                                <Route>Intraperitoneal (i.p.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Mice were primed with 60 μg ovalbumin in alum and then immunized 7-10 days later via the i.p. route with an ovalbumin-liposome formulation containing 100 μg ganglioside per mouse. Subsequent immunizations were administered at 2-week intervals. GalNAcT-/- mice possess only GM3 and GD3 gangliosides, lacking GD1a, GT1a, GQ1b, and GM1 gangliosides.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>IgG responses were not significantly cross-reactive between the LPS immunogen and the ganglioside antigen.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>GM1 ganglioside commercial preparation</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionNonSequenceMolecule>
                                        <ChemicalType>Other Non-Sequence</ChemicalType>
                                        <Molecule>
                                            <ChEBIId>CHEBI:18216</ChEBIId>
                                        </Molecule>
                                        <SourceOrganismId>7742</SourceOrganismId>
                                    </AccessionNonSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 3A</LocationOfData>
                        <BCellId>11687</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                                <Age>6-8 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Structurally Related</EpitopeRelation>
                                    <Object>
                                        <AccessionNonSequenceMolecule>
                                            <ChemicalType>Glycolipid</ChemicalType>
                                            <Molecule>
                                                <ChEBIId>CHEBI:18163</ChEBIId>
                                            </Molecule>
                                            <SourceOrganismId>7742</SourceOrganismId>
                                        </AccessionNonSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Ganglioside GD1a</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                                <Route>Intraperitoneal (i.p.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Mice were primed with 60 μg ovalbumin in alum and then immunized 7-10 days later via the i.p. route with an ovalbumin-liposome formulation containing 100μg ganglioside per mouse. Subsequent immunizations were administered at 2-week intervals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>IgM responses were not significantly cross-reactive between the immunogen and antigen gangliosides.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgM</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>GM1 ganglioside commercial preparation</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionNonSequenceMolecule>
                                        <ChemicalType>Other Non-Sequence</ChemicalType>
                                        <Molecule>
                                            <ChEBIId>CHEBI:18216</ChEBIId>
                                        </Molecule>
                                        <SourceOrganismId>7742</SourceOrganismId>
                                    </AccessionNonSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 5A</LocationOfData>
                        <BCellId>17697</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                                <Age>6-8 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Structurally Related</EpitopeRelation>
                                    <Object>
                                        <AccessionNonSequenceMolecule>
                                            <ChemicalType>Glycolipid</ChemicalType>
                                            <Molecule>
                                                <ChEBIId>CHEBI:35371</ChEBIId>
                                            </Molecule>
                                            <SourceOrganismId>10000717</SourceOrganismId>
                                        </AccessionNonSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>C. jejuni HS:4 LPS</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Route>Intraperitoneal (i.p.)</Route>
                                <DoseSchedule>Mice were primed with 100 μg LPS in 100-μl CFA and boosted in IFA at 2 week intervals.</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>IgM responses were not significantly cross-reactive between the LPS immunogen and the ganglioside antigen.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgM</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>GM1 ganglioside commercial preparation</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionNonSequenceMolecule>
                                        <ChemicalType>Other Non-Sequence</ChemicalType>
                                        <Molecule>
                                            <ChEBIId>CHEBI:18216</ChEBIId>
                                        </Molecule>
                                        <SourceOrganismId>7742</SourceOrganismId>
                                    </AccessionNonSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <BCellId>17690</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000006</OrganismId>
                                <Age>6-8 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Structurally Related</EpitopeRelation>
                                    <Object>
                                        <AccessionNonSequenceMolecule>
                                            <ChemicalType>Glycolipid</ChemicalType>
                                            <Molecule>
                                                <ChEBIId>CHEBI:28424</ChEBIId>
                                            </Molecule>
                                            <SourceOrganismId>7742</SourceOrganismId>
                                        </AccessionNonSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Ganglioside GD3</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                                <Route>Intraperitoneal (i.p.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Mice were primed with 60 μg ovalbumin in alum and then immunized 7-10 days later via the i.p. route with an ovalbumin-liposome formulation containing 100 μg ganglioside per mouse. Subsequent immunizations were administered at 2-week intervals. GalNAcT-/- mice possess only GM3 and GD3 gangliosides, lacking GD1a, GT1a, GQ1b, and GM1 gangliosides.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>No significant IgM or IgG responses were detected at any  time-points tested in GalNAcT -/- mice.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgM</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>GM1 ganglioside commercial preparation</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionNonSequenceMolecule>
                                        <ChemicalType>Other Non-Sequence</ChemicalType>
                                        <Molecule>
                                            <ChEBIId>CHEBI:18216</ChEBIId>
                                        </Molecule>
                                        <SourceOrganismId>7742</SourceOrganismId>
                                    </AccessionNonSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 3A</LocationOfData>
                        <BCellId>1803962</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                                <Age>6-8 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Structurally Related</EpitopeRelation>
                                    <Object>
                                        <AccessionNonSequenceMolecule>
                                            <ChemicalType>Glycolipid</ChemicalType>
                                            <Molecule>
                                                <ChEBIId>CHEBI:18163</ChEBIId>
                                            </Molecule>
                                            <SourceOrganismId>7742</SourceOrganismId>
                                        </AccessionNonSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Ganglioside GD1a</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                                <Route>Intraperitoneal (i.p.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Mice were primed with 60 μg ovalbumin in alum and then immunized 7-10 days later via the i.p. route with an ovalbumin-liposome formulation containing 100μg ganglioside per mouse. Subsequent immunizations were administered at 2-week intervals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>IgG responses were not significantly cross-reactive between the LPS immunogen and the ganglioside antigen.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>GM1 ganglioside commercial preparation</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionNonSequenceMolecule>
                                        <ChemicalType>Other Non-Sequence</ChemicalType>
                                        <Molecule>
                                            <ChEBIId>CHEBI:18216</ChEBIId>
                                        </Molecule>
                                        <SourceOrganismId>7742</SourceOrganismId>
                                    </AccessionNonSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 5B</LocationOfData>
                        <BCellId>17696</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000006</OrganismId>
                                <Age>6-8 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Structurally Related</EpitopeRelation>
                                    <Object>
                                        <AccessionNonSequenceMolecule>
                                            <ChemicalType>Carbohydrate</ChemicalType>
                                            <Molecule>
                                                <ChEBIId>CHEBI:35371</ChEBIId>
                                            </Molecule>
                                            <SourceOrganismId>10000716</SourceOrganismId>
                                        </AccessionNonSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>C. jejuni HS:19 LPS</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Route>Intraperitoneal (i.p.)</Route>
                                <DoseSchedule>Mice were primed with 100 μg LPS in 100-μl CFA and boosted in IFA at 2 week intervals.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>GalNAcT-/- mice possess only GM3 and GD3 gangliosides, lacking GD1a, GT1a, GQ1b, and GM1 gangliosides.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>IgM responses were not significantly cross-reactive between the LPS immunogen and the ganglioside antigen.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgM</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>GM1 ganglioside commercial preparation</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionNonSequenceMolecule>
                                        <ChemicalType>Other Non-Sequence</ChemicalType>
                                        <Molecule>
                                            <ChEBIId>CHEBI:18216</ChEBIId>
                                        </Molecule>
                                        <SourceOrganismId>7742</SourceOrganismId>
                                    </AccessionNonSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 3B</LocationOfData>
                        <BCellId>17689</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000006</OrganismId>
                                <Age>6-8 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Structurally Related</EpitopeRelation>
                                    <Object>
                                        <AccessionNonSequenceMolecule>
                                            <ChemicalType>Glycolipid</ChemicalType>
                                            <Molecule>
                                                <ChEBIId>CHEBI:27515</ChEBIId>
                                            </Molecule>
                                            <SourceOrganismId>7742</SourceOrganismId>
                                        </AccessionNonSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Ganglioside GQ1b</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                                <Route>Intraperitoneal (i.p.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Mice were primed with 60 μg ovalbumin in alum and then immunized 7-10 days later via the i.p. route with an ovalbumin-liposome formulation containing 100 μg ganglioside per mouse. Subsequent immunizations were administered at 2-week intervals. GalNAcT-/- mice possess only GM3 and GD3 gangliosides, lacking GD1a, GT1a, GQ1b, and GM1 gangliosides.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>IgM responses were not significantly cross-reactive between the immunogen and antigen gangliosides.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgM</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>GM1 ganglioside commercial preparation</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionNonSequenceMolecule>
                                        <ChemicalType>Other Non-Sequence</ChemicalType>
                                        <Molecule>
                                            <ChEBIId>CHEBI:18216</ChEBIId>
                                        </Molecule>
                                        <SourceOrganismId>7742</SourceOrganismId>
                                    </AccessionNonSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 5B</LocationOfData>
                        <BCellId>17698</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                                <Age>6-8 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Structurally Related</EpitopeRelation>
                                    <Object>
                                        <AccessionNonSequenceMolecule>
                                            <ChemicalType>Carbohydrate</ChemicalType>
                                            <Molecule>
                                                <ChEBIId>CHEBI:35371</ChEBIId>
                                            </Molecule>
                                            <SourceOrganismId>10000716</SourceOrganismId>
                                        </AccessionNonSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>C. jejuni HS:19 LPS</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Route>Intraperitoneal (i.p.)</Route>
                                <DoseSchedule>Mice were primed with 100 μg LPS in 100-μl CFA and boosted in IFA at 2 week intervals.</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>IgM responses were not significantly cross-reactive between the LPS immunogen and the ganglioside antigen.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgM</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>GM1 ganglioside commercial preparation</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionNonSequenceMolecule>
                                        <ChemicalType>Other Non-Sequence</ChemicalType>
                                        <Molecule>
                                            <ChEBIId>CHEBI:18216</ChEBIId>
                                        </Molecule>
                                        <SourceOrganismId>7742</SourceOrganismId>
                                    </AccessionNonSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 5A</LocationOfData>
                        <BCellId>17695</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000006</OrganismId>
                                <Age>6-8 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Structurally Related</EpitopeRelation>
                                    <Object>
                                        <AccessionNonSequenceMolecule>
                                            <ChemicalType>Glycolipid</ChemicalType>
                                            <Molecule>
                                                <ChEBIId>CHEBI:35371</ChEBIId>
                                            </Molecule>
                                            <SourceOrganismId>10000717</SourceOrganismId>
                                        </AccessionNonSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>C. jejuni HS:4 LPS</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Route>Intraperitoneal (i.p.)</Route>
                                <DoseSchedule>Mice were primed with 100 μg LPS in 100-μl CFA and boosted in IFA at 2 week intervals.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Mice were primed with 60 μg ovalbumin in alum and then immunized 7-10 days later via the i.p. route with an ovalbumin-liposome formulation containing 100 μg ganglioside per mouse. Subsequent immunizations were administered at 2-week intervals. GalNAcT-/- mice possess only GM3 and GD3 gangliosides, lacking GD1a, GT1a, GQ1b, and GM1 gangliosides.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>IgM responses were not significantly cross-reactive between the LPS immunogen and the ganglioside antigen.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>anti-GM1 ganglioside Ab</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgM</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>GM1 ganglioside commercial preparation</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionNonSequenceMolecule>
                                        <ChemicalType>Other Non-Sequence</ChemicalType>
                                        <Molecule>
                                            <ChEBIId>CHEBI:18216</ChEBIId>
                                        </Molecule>
                                        <SourceOrganismId>7742</SourceOrganismId>
                                    </AccessionNonSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <BCellId>17694</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                                <Age>6-8 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Structurally Related</EpitopeRelation>
                                    <Object>
                                        <AccessionNonSequenceMolecule>
                                            <ChemicalType>Glycolipid</ChemicalType>
                                            <Molecule>
                                                <ChEBIId>CHEBI:28424</ChEBIId>
                                            </Molecule>
                                            <SourceOrganismId>7742</SourceOrganismId>
                                        </AccessionNonSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Ganglioside GD3</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                                <Route>Intraperitoneal (i.p.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Mice were primed with 60 μg ovalbumin in alum and then immunized 7-10 days later via the i.p. route with an ovalbumin-liposome formulation containing 100μg ganglioside per mouse. Subsequent immunizations were administered at 2-week intervals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>No significant IgM or IgG responses were detected at any  time-points tested in GalNAcT +/+ mice.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgM</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>GM1 ganglioside commercial preparation</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionNonSequenceMolecule>
                                        <ChemicalType>Other Non-Sequence</ChemicalType>
                                        <Molecule>
                                            <ChEBIId>CHEBI:18216</ChEBIId>
                                        </Molecule>
                                        <SourceOrganismId>7742</SourceOrganismId>
                                    </AccessionNonSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>GD1a carbohydrate epitope</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalNonSequenceMolecule>
                        <ChemicalType>Carbohydrate fragment</ChemicalType>
                        <Molecule>
                            <ChEBIId>CHEBI:59209</ChEBIId>
                        </Molecule>
                        <SourceMolecule>
                            <ChEBIId>CHEBI:18163</ChEBIId>
                        </SourceMolecule>
                        <SourceOrganismId>7742</SourceOrganismId>
                    </FragmentOfANaturalNonSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 1</LocationOfData>
                <EpitopeId>130677</EpitopeId>
                <EpitopeEvidenceCode>Exact match to reference information</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The epitope is deduced to be the carbohydrate moiety from the lack of cross-reactivity towards other gangliosides.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 3A</LocationOfData>
                        <BCellId>11703</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000006</OrganismId>
                                <Age>6-8 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionNonSequenceMolecule>
                                            <ChemicalType>Other Non-Sequence</ChemicalType>
                                            <Molecule>
                                                <ChEBIId>CHEBI:18163</ChEBIId>
                                            </Molecule>
                                            <SourceOrganismId>7742</SourceOrganismId>
                                        </AccessionNonSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Ganglioside GD1a</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                                <Route>Intraperitoneal (i.p.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Mice were primed with 60 μg ovalbumin in alum and then immunized 7-10 days later via the i.p. route with an ovalbumin-liposome formulation containing 100 μg ganglioside per mouse. Subsequent immunizations were administered at 2-week intervals. GalNAcT-/- mice possess only GM3 and GD3 gangliosides, lacking GD1a, GT1a, GQ1b, and GM1 gangliosides.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>A significant IgG response detected in GalNAcT -/- mice after the 2nd and 3rd immunizations.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>GD1a ganglioside commercial preparation</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionNonSequenceMolecule>
                                        <ChemicalType>Other Non-Sequence</ChemicalType>
                                        <Molecule>
                                            <ChEBIId>CHEBI:18163</ChEBIId>
                                        </Molecule>
                                        <SourceOrganismId>7742</SourceOrganismId>
                                    </AccessionNonSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 5A</LocationOfData>
                        <BCellId>17702</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000006</OrganismId>
                                <Age>6-8 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Structurally Related</EpitopeRelation>
                                    <Object>
                                        <AccessionNonSequenceMolecule>
                                            <ChemicalType>Glycolipid</ChemicalType>
                                            <Molecule>
                                                <ChEBIId>CHEBI:35371</ChEBIId>
                                            </Molecule>
                                            <SourceOrganismId>10000717</SourceOrganismId>
                                        </AccessionNonSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>C. jejuni HS:4 LPS</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Route>Intraperitoneal (i.p.)</Route>
                                <DoseSchedule>Mice were primed with 100 μg LPS in 100-μl CFA and boosted in IFA at 2 week intervals.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>GalNAcT-/- mice possess only GM3 and GD3 gangliosides, lacking GD1a, GT1a, GQ1b, and GM1 gangliosides.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>IgM responses were not significant.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgM</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>GD1a ganglioside commercial preparation</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionNonSequenceMolecule>
                                        <ChemicalType>Other Non-Sequence</ChemicalType>
                                        <Molecule>
                                            <ChEBIId>CHEBI:18163</ChEBIId>
                                        </Molecule>
                                        <SourceOrganismId>7742</SourceOrganismId>
                                    </AccessionNonSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 3A</LocationOfData>
                        <BCellId>1803977</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                                <Age>6-8 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionNonSequenceMolecule>
                                            <ChemicalType>Other Non-Sequence</ChemicalType>
                                            <Molecule>
                                                <ChEBIId>CHEBI:18163</ChEBIId>
                                            </Molecule>
                                            <SourceOrganismId>7742</SourceOrganismId>
                                        </AccessionNonSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Ganglioside GD1a</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                                <Route>Intraperitoneal (i.p.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Mice were primed with 60 μg ovalbumin in alum and then immunized 7-10 days later via the i.p. route with an ovalbumin-liposome formulation containing 100μg ganglioside per mouse. Subsequent immunizations were administered at 2-week intervals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgM</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>GD1a ganglioside commercial preparation</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionNonSequenceMolecule>
                                        <ChemicalType>Other Non-Sequence</ChemicalType>
                                        <Molecule>
                                            <ChEBIId>CHEBI:18163</ChEBIId>
                                        </Molecule>
                                        <SourceOrganismId>7742</SourceOrganismId>
                                    </AccessionNonSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 5A</LocationOfData>
                        <BCellId>1804191</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                                <Age>6-8 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Structurally Related</EpitopeRelation>
                                    <Object>
                                        <AccessionNonSequenceMolecule>
                                            <ChemicalType>Glycolipid</ChemicalType>
                                            <Molecule>
                                                <ChEBIId>CHEBI:35371</ChEBIId>
                                            </Molecule>
                                            <SourceOrganismId>10000717</SourceOrganismId>
                                        </AccessionNonSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>C. jejuni HS:4 LPS</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Route>Intraperitoneal (i.p.)</Route>
                                <DoseSchedule>Mice were primed with 100 μg LPS in 100-μl CFA and boosted in IFA at 2 week intervals.</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>IgM responses were not significant.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgM</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>GD1a ganglioside commercial preparation</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionNonSequenceMolecule>
                                        <ChemicalType>Other Non-Sequence</ChemicalType>
                                        <Molecule>
                                            <ChEBIId>CHEBI:18163</ChEBIId>
                                        </Molecule>
                                        <SourceOrganismId>7742</SourceOrganismId>
                                    </AccessionNonSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 5A</LocationOfData>
                        <BCellId>1804192</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                                <Age>6-8 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Structurally Related</EpitopeRelation>
                                    <Object>
                                        <AccessionNonSequenceMolecule>
                                            <ChemicalType>Glycolipid</ChemicalType>
                                            <Molecule>
                                                <ChEBIId>CHEBI:35371</ChEBIId>
                                            </Molecule>
                                            <SourceOrganismId>10000717</SourceOrganismId>
                                        </AccessionNonSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>C. jejuni HS:4 LPS</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Route>Intraperitoneal (i.p.)</Route>
                                <DoseSchedule>Mice were primed with 100 μg LPS in 100-μl CFA and boosted in IFA at 2 week intervals.</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>IgG responses were not significant.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>GD1a ganglioside commercial preparation</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionNonSequenceMolecule>
                                        <ChemicalType>Other Non-Sequence</ChemicalType>
                                        <Molecule>
                                            <ChEBIId>CHEBI:18163</ChEBIId>
                                        </Molecule>
                                        <SourceOrganismId>7742</SourceOrganismId>
                                    </AccessionNonSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 3A</LocationOfData>
                        <BCellId>1803951</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000006</OrganismId>
                                <Age>6-8 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionNonSequenceMolecule>
                                            <ChemicalType>Other Non-Sequence</ChemicalType>
                                            <Molecule>
                                                <ChEBIId>CHEBI:18163</ChEBIId>
                                            </Molecule>
                                            <SourceOrganismId>7742</SourceOrganismId>
                                        </AccessionNonSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Ganglioside GD1a</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                                <Route>Intraperitoneal (i.p.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Mice were primed with 60 μg ovalbumin in alum and then immunized 7-10 days later via the i.p. route with an ovalbumin-liposome formulation containing 100 μg ganglioside per mouse. Subsequent immunizations were administered at 2-week intervals. GalNAcT-/- mice possess only GM3 and GD3 gangliosides, lacking GD1a, GT1a, GQ1b, and GM1 gangliosides.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgM</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>GD1a ganglioside commercial preparation</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionNonSequenceMolecule>
                                        <ChemicalType>Other Non-Sequence</ChemicalType>
                                        <Molecule>
                                            <ChEBIId>CHEBI:18163</ChEBIId>
                                        </Molecule>
                                        <SourceOrganismId>7742</SourceOrganismId>
                                    </AccessionNonSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 3A</LocationOfData>
                        <BCellId>17700</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                                <Age>6-8 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionNonSequenceMolecule>
                                            <ChemicalType>Other Non-Sequence</ChemicalType>
                                            <Molecule>
                                                <ChEBIId>CHEBI:18163</ChEBIId>
                                            </Molecule>
                                            <SourceOrganismId>7742</SourceOrganismId>
                                        </AccessionNonSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Ganglioside GD1a</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                                <Route>Intraperitoneal (i.p.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Mice were primed with 60 μg ovalbumin in alum and then immunized 7-10 days later via the i.p. route with an ovalbumin-liposome formulation containing 100μg ganglioside per mouse. Subsequent immunizations were administered at 2-week intervals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>Sera was assayed for IgG Ab response to immunogen with no significant IgG detected at any time point. Serum IgM titers were also similar to controls.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>GD1a ganglioside commercial preparation</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionNonSequenceMolecule>
                                        <ChemicalType>Other Non-Sequence</ChemicalType>
                                        <Molecule>
                                            <ChEBIId>CHEBI:18163</ChEBIId>
                                        </Molecule>
                                        <SourceOrganismId>7742</SourceOrganismId>
                                    </AccessionNonSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 5A</LocationOfData>
                        <BCellId>17701</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000006</OrganismId>
                                <Age>6-8 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Structurally Related</EpitopeRelation>
                                    <Object>
                                        <AccessionNonSequenceMolecule>
                                            <ChemicalType>Glycolipid</ChemicalType>
                                            <Molecule>
                                                <ChEBIId>CHEBI:35371</ChEBIId>
                                            </Molecule>
                                            <SourceOrganismId>10000717</SourceOrganismId>
                                        </AccessionNonSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>C. jejuni HS:4 LPS</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Route>Intraperitoneal (i.p.)</Route>
                                <DoseSchedule>Mice were primed with 100 μg LPS in 100-μl CFA and boosted in IFA at 2 week intervals.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>GalNAcT-/- mice possess only GM3 and GD3 gangliosides, lacking GD1a, GT1a, GQ1b, and GM1 gangliosides.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>A significant IgG response was detected in GalNAcT -/- mice after the 3rd immunization.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>GD1a ganglioside commercial preparation</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionNonSequenceMolecule>
                                        <ChemicalType>Other Non-Sequence</ChemicalType>
                                        <Molecule>
                                            <ChEBIId>CHEBI:18163</ChEBIId>
                                        </Molecule>
                                        <SourceOrganismId>7742</SourceOrganismId>
                                    </AccessionNonSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>GD3 carbohydrate epitope</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalNonSequenceMolecule>
                        <ChemicalType>Carbohydrate fragment</ChemicalType>
                        <Molecule>
                            <ChEBIId>CHEBI:59210</ChEBIId>
                        </Molecule>
                        <SourceMolecule>
                            <ChEBIId>CHEBI:28424</ChEBIId>
                        </SourceMolecule>
                        <SourceOrganismId>7742</SourceOrganismId>
                    </FragmentOfANaturalNonSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 1</LocationOfData>
                <EpitopeId>130676</EpitopeId>
                <EpitopeEvidenceCode>Exact match to reference information</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The epitope is deduced to be the carbohydrate moiety from the lack of cross-reactivity towards other gangliosides.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 3B</LocationOfData>
                        <BCellId>11716</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000006</OrganismId>
                                <Age>6-8 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Structurally Related</EpitopeRelation>
                                    <Object>
                                        <AccessionNonSequenceMolecule>
                                            <ChemicalType>Glycolipid</ChemicalType>
                                            <Molecule>
                                                <ChEBIId>CHEBI:27515</ChEBIId>
                                            </Molecule>
                                            <SourceOrganismId>7742</SourceOrganismId>
                                        </AccessionNonSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Ganglioside GQ1b</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                                <Route>Intraperitoneal (i.p.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Mice were primed with 60 μg ovalbumin in alum and then immunized 7-10 days later via the i.p. route with an ovalbumin-liposome formulation containing 100 μg ganglioside per mouse. Subsequent immunizations were administered at 2-week intervals. GalNAcT-/- mice possess only GM3 and GD3 gangliosides, lacking GD1a, GT1a, GQ1b, and GM1 gangliosides.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>IgM and IgG responses were not significant.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgM</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>GD3 ganglioside commercial preparation</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionNonSequenceMolecule>
                                        <ChemicalType>Carbohydrate</ChemicalType>
                                        <Molecule>
                                            <ChEBIId>CHEBI:28424</ChEBIId>
                                        </Molecule>
                                        <SourceOrganismId>7742</SourceOrganismId>
                                    </AccessionNonSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <BCellId>17705</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000006</OrganismId>
                                <Age>6 - 8 wo</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionNonSequenceMolecule>
                                            <ChemicalType>Carbohydrate</ChemicalType>
                                            <Molecule>
                                                <ChEBIId>CHEBI:28424</ChEBIId>
                                            </Molecule>
                                            <SourceOrganismId>7742</SourceOrganismId>
                                        </AccessionNonSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Ganglioside GD3</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                                <Route>Intraperitoneal (i.p.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Mice were primed with 60 μg ovalbumin in alum and then immunized 7-10 days later via the i.p. route with an ovalbumin-liposome formulation containing 100 μg ganglioside per mouse. Subsequent immunizations were administered at 2-week intervals. GalNAcT-/- mice possess only GM3 and GD3 gangliosides, lacking GD1a, GT1a, GQ1b, and GM1 gangliosides.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>No significant increases in serum IgM or IgG titres was seen at any immunization time point in GalNAcT -/- mice.  In contrast, homozygous +/+ mice produced significant IgM and IgG responses.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgM</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>GD3 ganglioside commercial preparation</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionNonSequenceMolecule>
                                        <ChemicalType>Carbohydrate</ChemicalType>
                                        <Molecule>
                                            <ChEBIId>CHEBI:28424</ChEBIId>
                                        </Molecule>
                                        <SourceOrganismId>7742</SourceOrganismId>
                                    </AccessionNonSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 5B</LocationOfData>
                        <BCellId>1804193</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                                <Age>6-8 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Structurally Related</EpitopeRelation>
                                    <Object>
                                        <AccessionNonSequenceMolecule>
                                            <ChemicalType>Carbohydrate</ChemicalType>
                                            <Molecule>
                                                <ChEBIId>CHEBI:35371</ChEBIId>
                                            </Molecule>
                                            <SourceOrganismId>10000716</SourceOrganismId>
                                        </AccessionNonSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>C. jejuni HS:19 LPS</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Route>Intraperitoneal (i.p.)</Route>
                                <DoseSchedule>Mice were primed with 100 μg LPS in 100-μl CFA and boosted in IFA at 2 week intervals.</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgM</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>GD3 ganglioside commercial preparation</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionNonSequenceMolecule>
                                        <ChemicalType>Carbohydrate</ChemicalType>
                                        <Molecule>
                                            <ChEBIId>CHEBI:28424</ChEBIId>
                                        </Molecule>
                                        <SourceOrganismId>7742</SourceOrganismId>
                                    </AccessionNonSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 5B</LocationOfData>
                        <BCellId>1804194</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000006</OrganismId>
                                <Age>6-8 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Structurally Related</EpitopeRelation>
                                    <Object>
                                        <AccessionNonSequenceMolecule>
                                            <ChemicalType>Carbohydrate</ChemicalType>
                                            <Molecule>
                                                <ChEBIId>CHEBI:35371</ChEBIId>
                                            </Molecule>
                                            <SourceOrganismId>10000716</SourceOrganismId>
                                        </AccessionNonSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>C. jejuni HS:19 LPS</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Route>Intraperitoneal (i.p.)</Route>
                                <DoseSchedule>Mice were primed with 100 μg LPS in 100-μl CFA and boosted in IFA at 2 week intervals.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>GalNAcT-/- mice possess only GM3 and GD3 gangliosides, lacking GD1a, GT1a, GQ1b, and GM1 gangliosides.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The IgGM responses were not significant.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgM</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>GD3 ganglioside commercial preparation</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionNonSequenceMolecule>
                                        <ChemicalType>Carbohydrate</ChemicalType>
                                        <Molecule>
                                            <ChEBIId>CHEBI:28424</ChEBIId>
                                        </Molecule>
                                        <SourceOrganismId>7742</SourceOrganismId>
                                    </AccessionNonSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <BCellId>1804195</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                                <Age>6-8 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionNonSequenceMolecule>
                                            <ChemicalType>Carbohydrate</ChemicalType>
                                            <Molecule>
                                                <ChEBIId>CHEBI:28424</ChEBIId>
                                            </Molecule>
                                            <SourceOrganismId>7742</SourceOrganismId>
                                        </AccessionNonSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Ganglioside GD3</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                                <Route>Intraperitoneal (i.p.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Mice were primed with 60 μg ovalbumin in alum and then immunized 7-10 days later via the i.p. route with an ovalbumin-liposome formulation containing 100μg ganglioside per mouse. Subsequent immunizations were administered at 2-week intervals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>4</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>3</NumberOfSubjectsResponded>
                            <ResponseFrequency>75</ResponseFrequency>
                            <AssayComments>Significant IgM increases througout successive immunizations of GalNAcT +/+ mice were observed.  Sera was also assayed for IgG Ab response to immunogen with significant increases in IgG titres after the second and third immunizations.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>GD3 ganglioside commercial preparation</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionNonSequenceMolecule>
                                        <ChemicalType>Carbohydrate</ChemicalType>
                                        <Molecule>
                                            <ChEBIId>CHEBI:28424</ChEBIId>
                                        </Molecule>
                                        <SourceOrganismId>7742</SourceOrganismId>
                                    </AccessionNonSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <BCellId>1804196</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000006</OrganismId>
                                <Age>6 - 8 wo</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionNonSequenceMolecule>
                                            <ChemicalType>Carbohydrate</ChemicalType>
                                            <Molecule>
                                                <ChEBIId>CHEBI:28424</ChEBIId>
                                            </Molecule>
                                            <SourceOrganismId>7742</SourceOrganismId>
                                        </AccessionNonSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Ganglioside GD3</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                                <Route>Intraperitoneal (i.p.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Mice were primed with 60 μg ovalbumin in alum and then immunized 7-10 days later via the i.p. route with an ovalbumin-liposome formulation containing 100 μg ganglioside per mouse. Subsequent immunizations were administered at 2-week intervals. GalNAcT-/- mice possess only GM3 and GD3 gangliosides, lacking GD1a, GT1a, GQ1b, and GM1 gangliosides.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>No significant increases in serum IgM or IgG titres was seen at any immunization time point in GalNAcT -/- mice.  In contrast, homozygous +/+ mice produced significant IgM and IgG responses.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>GD3 ganglioside commercial preparation</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionNonSequenceMolecule>
                                        <ChemicalType>Carbohydrate</ChemicalType>
                                        <Molecule>
                                            <ChEBIId>CHEBI:28424</ChEBIId>
                                        </Molecule>
                                        <SourceOrganismId>7742</SourceOrganismId>
                                    </AccessionNonSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 3B</LocationOfData>
                        <BCellId>1804197</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                                <Age>6-8 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Structurally Related</EpitopeRelation>
                                    <Object>
                                        <AccessionNonSequenceMolecule>
                                            <ChemicalType>Glycolipid</ChemicalType>
                                            <Molecule>
                                                <ChEBIId>CHEBI:27515</ChEBIId>
                                            </Molecule>
                                            <SourceOrganismId>7742</SourceOrganismId>
                                        </AccessionNonSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Ganglioside GQ1b</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                                <Route>Intraperitoneal (i.p.)</Route>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>IgM and IgG responses were not significant.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgM</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>GD3 ganglioside commercial preparation</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionNonSequenceMolecule>
                                        <ChemicalType>Carbohydrate</ChemicalType>
                                        <Molecule>
                                            <ChEBIId>CHEBI:28424</ChEBIId>
                                        </Molecule>
                                        <SourceOrganismId>7742</SourceOrganismId>
                                    </AccessionNonSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 3B</LocationOfData>
                        <BCellId>1804198</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                                <Age>6-8 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Structurally Related</EpitopeRelation>
                                    <Object>
                                        <AccessionNonSequenceMolecule>
                                            <ChemicalType>Glycolipid</ChemicalType>
                                            <Molecule>
                                                <ChEBIId>CHEBI:27515</ChEBIId>
                                            </Molecule>
                                            <SourceOrganismId>7742</SourceOrganismId>
                                        </AccessionNonSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Ganglioside GQ1b</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                                <Route>Intraperitoneal (i.p.)</Route>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>IgM and IgG responses were not significant.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>GD3 ganglioside commercial preparation</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionNonSequenceMolecule>
                                        <ChemicalType>Carbohydrate</ChemicalType>
                                        <Molecule>
                                            <ChEBIId>CHEBI:28424</ChEBIId>
                                        </Molecule>
                                        <SourceOrganismId>7742</SourceOrganismId>
                                    </AccessionNonSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <BCellId>17718</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                                <Age>6-8 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionNonSequenceMolecule>
                                            <ChemicalType>Carbohydrate</ChemicalType>
                                            <Molecule>
                                                <ChEBIId>CHEBI:28424</ChEBIId>
                                            </Molecule>
                                            <SourceOrganismId>7742</SourceOrganismId>
                                        </AccessionNonSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Ganglioside GD3</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                                <Route>Intraperitoneal (i.p.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Mice were primed with 60 μg ovalbumin in alum and then immunized 7-10 days later via the i.p. route with an ovalbumin-liposome formulation containing 100μg ganglioside per mouse. Subsequent immunizations were administered at 2-week intervals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>5</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>4</NumberOfSubjectsResponded>
                            <ResponseFrequency>80</ResponseFrequency>
                            <AssayComments>Significant IgM increases througout successive immunizations of GalNAcT +/+ mice were observed.  Sera was also assayed for IgG Ab response to immunogen with significant increases in IgG titres after the second and third immunizations.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgM</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>GD3 ganglioside commercial preparation</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionNonSequenceMolecule>
                                        <ChemicalType>Carbohydrate</ChemicalType>
                                        <Molecule>
                                            <ChEBIId>CHEBI:28424</ChEBIId>
                                        </Molecule>
                                        <SourceOrganismId>7742</SourceOrganismId>
                                    </AccessionNonSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 5B</LocationOfData>
                        <BCellId>17719</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                                <Age>6-8 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Structurally Related</EpitopeRelation>
                                    <Object>
                                        <AccessionNonSequenceMolecule>
                                            <ChemicalType>Carbohydrate</ChemicalType>
                                            <Molecule>
                                                <ChEBIId>CHEBI:35371</ChEBIId>
                                            </Molecule>
                                            <SourceOrganismId>10000716</SourceOrganismId>
                                        </AccessionNonSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>C. jejuni HS:19 LPS</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Route>Intraperitoneal (i.p.)</Route>
                                <DoseSchedule>Mice were primed with 100 μg LPS in 100-μl CFA and boosted in IFA at 2 week intervals.</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>GD3 ganglioside commercial preparation</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionNonSequenceMolecule>
                                        <ChemicalType>Carbohydrate</ChemicalType>
                                        <Molecule>
                                            <ChEBIId>CHEBI:28424</ChEBIId>
                                        </Molecule>
                                        <SourceOrganismId>7742</SourceOrganismId>
                                    </AccessionNonSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 5B</LocationOfData>
                        <BCellId>17721</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000006</OrganismId>
                                <Age>6-8 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Structurally Related</EpitopeRelation>
                                    <Object>
                                        <AccessionNonSequenceMolecule>
                                            <ChemicalType>Carbohydrate</ChemicalType>
                                            <Molecule>
                                                <ChEBIId>CHEBI:35371</ChEBIId>
                                            </Molecule>
                                            <SourceOrganismId>10000716</SourceOrganismId>
                                        </AccessionNonSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>C. jejuni HS:19 LPS</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Route>Intraperitoneal (i.p.)</Route>
                                <DoseSchedule>Mice were primed with 100 μg LPS in 100-μl CFA and boosted in IFA at 2 week intervals.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>GalNAcT-/- mice possess only GM3 and GD3 gangliosides, lacking GD1a, GT1a, GQ1b, and GM1 gangliosides.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The IgG responses were not significant.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>GD3 ganglioside commercial preparation</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionNonSequenceMolecule>
                                        <ChemicalType>Carbohydrate</ChemicalType>
                                        <Molecule>
                                            <ChEBIId>CHEBI:28424</ChEBIId>
                                        </Molecule>
                                        <SourceOrganismId>7742</SourceOrganismId>
                                    </AccessionNonSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 3B</LocationOfData>
                        <BCellId>17703</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000006</OrganismId>
                                <Age>6-8 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Structurally Related</EpitopeRelation>
                                    <Object>
                                        <AccessionNonSequenceMolecule>
                                            <ChemicalType>Glycolipid</ChemicalType>
                                            <Molecule>
                                                <ChEBIId>CHEBI:27515</ChEBIId>
                                            </Molecule>
                                            <SourceOrganismId>7742</SourceOrganismId>
                                        </AccessionNonSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Ganglioside GQ1b</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                                <Route>Intraperitoneal (i.p.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Mice were primed with 60 μg ovalbumin in alum and then immunized 7-10 days later via the i.p. route with an ovalbumin-liposome formulation containing 100 μg ganglioside per mouse. Subsequent immunizations were administered at 2-week intervals. GalNAcT-/- mice possess only GM3 and GD3 gangliosides, lacking GD1a, GT1a, GQ1b, and GM1 gangliosides.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>IgM and IgG responses were not significant.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>GD3 ganglioside commercial preparation</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionNonSequenceMolecule>
                                        <ChemicalType>Carbohydrate</ChemicalType>
                                        <Molecule>
                                            <ChEBIId>CHEBI:28424</ChEBIId>
                                        </Molecule>
                                        <SourceOrganismId>7742</SourceOrganismId>
                                    </AccessionNonSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>GQ1b carbohydrate epitope</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalNonSequenceMolecule>
                        <ChemicalType>Carbohydrate fragment</ChemicalType>
                        <Molecule>
                            <ChEBIId>CHEBI:59212</ChEBIId>
                        </Molecule>
                        <SourceMolecule>
                            <ChEBIId>CHEBI:27515</ChEBIId>
                        </SourceMolecule>
                        <SourceOrganismId>7742</SourceOrganismId>
                    </FragmentOfANaturalNonSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 1</LocationOfData>
                <EpitopeId>130675</EpitopeId>
                <EpitopeEvidenceCode>Exact match to reference information</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The epitope is deduced to be the carbohydrate moiety from the lack of cross-reactivity towards other gangliosides.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 3B</LocationOfData>
                        <BCellId>11721</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000006</OrganismId>
                                <Age>6-8 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionNonSequenceMolecule>
                                            <ChemicalType>Carbohydrate</ChemicalType>
                                            <Molecule>
                                                <ChEBIId>CHEBI:27515</ChEBIId>
                                            </Molecule>
                                            <SourceOrganismId>7742</SourceOrganismId>
                                        </AccessionNonSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Ganglioside GQ1b</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                                <Route>Intraperitoneal (i.p.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Mice were primed with 60 μg ovalbumin in alum and then immunized 7-10 days later via the i.p. route with an ovalbumin-liposome formulation containing 100 μg ganglioside per mouse. Subsequent immunizations were administered at 2-week intervals. GalNAcT-/- mice possess only GM3 and GD3 gangliosides, lacking GD1a, GT1a, GQ1b, and GM1 gangliosides.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>A significant IgG response (P&lt;0.001) was detected in GalNAcT -/- mice after the 2nd and 3rd immunizations.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>GQ1b ganglioside commercial preparation</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionNonSequenceMolecule>
                                        <ChemicalType>Carbohydrate</ChemicalType>
                                        <Molecule>
                                            <ChEBIId>CHEBI:27515</ChEBIId>
                                        </Molecule>
                                        <SourceOrganismId>7742</SourceOrganismId>
                                    </AccessionNonSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 3B</LocationOfData>
                        <BCellId>1804199</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000006</OrganismId>
                                <Age>6-8 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionNonSequenceMolecule>
                                            <ChemicalType>Carbohydrate</ChemicalType>
                                            <Molecule>
                                                <ChEBIId>CHEBI:27515</ChEBIId>
                                            </Molecule>
                                            <SourceOrganismId>7742</SourceOrganismId>
                                        </AccessionNonSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Ganglioside GQ1b</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                                <Route>Intraperitoneal (i.p.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Mice were primed with 60 μg ovalbumin in alum and then immunized 7-10 days later via the i.p. route with an ovalbumin-liposome formulation containing 100 μg ganglioside per mouse. Subsequent immunizations were administered at 2-week intervals. GalNAcT-/- mice possess only GM3 and GD3 gangliosides, lacking GD1a, GT1a, GQ1b, and GM1 gangliosides.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The response was not significant.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgM</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>GQ1b ganglioside commercial preparation</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionNonSequenceMolecule>
                                        <ChemicalType>Carbohydrate</ChemicalType>
                                        <Molecule>
                                            <ChEBIId>CHEBI:27515</ChEBIId>
                                        </Molecule>
                                        <SourceOrganismId>7742</SourceOrganismId>
                                    </AccessionNonSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 3B</LocationOfData>
                        <BCellId>1804200</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                                <Age>6 - 8 wo</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionNonSequenceMolecule>
                                            <ChemicalType>Carbohydrate</ChemicalType>
                                            <Molecule>
                                                <ChEBIId>CHEBI:27515</ChEBIId>
                                            </Molecule>
                                            <SourceOrganismId>7742</SourceOrganismId>
                                        </AccessionNonSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Ganglioside GQ1b</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                                <Route>Intraperitoneal (i.p.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Mice were primed with 60 μg ovalbumin in alum and then immunized 7-10 days later via the i.p. route with an ovalbumin-liposome formulation containing 100μg ganglioside per mouse. Subsequent immunizations were administered at 2-week intervals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The response was not significant.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgM</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>GQ1b ganglioside commercial preparation</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionNonSequenceMolecule>
                                        <ChemicalType>Carbohydrate</ChemicalType>
                                        <Molecule>
                                            <ChEBIId>CHEBI:27515</ChEBIId>
                                        </Molecule>
                                        <SourceOrganismId>7742</SourceOrganismId>
                                    </AccessionNonSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 5B</LocationOfData>
                        <BCellId>1804201</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000006</OrganismId>
                                <Age>6 - 8 wo</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Structurally Related</EpitopeRelation>
                                    <Object>
                                        <AccessionNonSequenceMolecule>
                                            <ChemicalType>Carbohydrate</ChemicalType>
                                            <Molecule>
                                                <ChEBIId>CHEBI:35371</ChEBIId>
                                            </Molecule>
                                            <SourceOrganismId>10000716</SourceOrganismId>
                                        </AccessionNonSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>C. jejuni HS:19 LPS</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Route>Intraperitoneal (i.p.)</Route>
                                <DoseSchedule>Mice were primed with 100 μg LPS in 100-μl CFA and boosted in IFA at 2 week intervals.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>GalNAcT-/- mice possess only GM3 and GD3 gangliosides, lacking GD1a, GT1a, GQ1b, and GM1 gangliosides.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgM</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>GQ1b ganglioside commercial preparation</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionNonSequenceMolecule>
                                        <ChemicalType>Carbohydrate</ChemicalType>
                                        <Molecule>
                                            <ChEBIId>CHEBI:27515</ChEBIId>
                                        </Molecule>
                                        <SourceOrganismId>7742</SourceOrganismId>
                                    </AccessionNonSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 5B</LocationOfData>
                        <BCellId>1804202</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                                <Age>6-8 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Structurally Related</EpitopeRelation>
                                    <Object>
                                        <AccessionNonSequenceMolecule>
                                            <ChemicalType>Carbohydrate</ChemicalType>
                                            <Molecule>
                                                <ChEBIId>CHEBI:35371</ChEBIId>
                                            </Molecule>
                                            <SourceOrganismId>10000716</SourceOrganismId>
                                        </AccessionNonSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>C. jejuni HS:19 LPS</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Route>Intraperitoneal (i.p.)</Route>
                                <DoseSchedule>Mice were primed with 100 μg LPS in 100-μl CFA and boosted in IFA at 2 week intervals.</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgM</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>GQ1b ganglioside commercial preparation</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionNonSequenceMolecule>
                                        <ChemicalType>Carbohydrate</ChemicalType>
                                        <Molecule>
                                            <ChEBIId>CHEBI:27515</ChEBIId>
                                        </Molecule>
                                        <SourceOrganismId>7742</SourceOrganismId>
                                    </AccessionNonSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 5B</LocationOfData>
                        <BCellId>17716</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                                <Age>6-8 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Structurally Related</EpitopeRelation>
                                    <Object>
                                        <AccessionNonSequenceMolecule>
                                            <ChemicalType>Carbohydrate</ChemicalType>
                                            <Molecule>
                                                <ChEBIId>CHEBI:35371</ChEBIId>
                                            </Molecule>
                                            <SourceOrganismId>10000716</SourceOrganismId>
                                        </AccessionNonSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>C. jejuni HS:19 LPS</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Route>Intraperitoneal (i.p.)</Route>
                                <DoseSchedule>Mice were primed with 100 μg LPS in 100-μl CFA and boosted in IFA at 2 week intervals.</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>GQ1b ganglioside commercial preparation</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionNonSequenceMolecule>
                                        <ChemicalType>Carbohydrate</ChemicalType>
                                        <Molecule>
                                            <ChEBIId>CHEBI:27515</ChEBIId>
                                        </Molecule>
                                        <SourceOrganismId>7742</SourceOrganismId>
                                    </AccessionNonSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 5B</LocationOfData>
                        <BCellId>17715</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000006</OrganismId>
                                <Age>6 - 8 wo</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Structurally Related</EpitopeRelation>
                                    <Object>
                                        <AccessionNonSequenceMolecule>
                                            <ChemicalType>Carbohydrate</ChemicalType>
                                            <Molecule>
                                                <ChEBIId>CHEBI:35371</ChEBIId>
                                            </Molecule>
                                            <SourceOrganismId>10000716</SourceOrganismId>
                                        </AccessionNonSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>C. jejuni HS:19 LPS</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Route>Intraperitoneal (i.p.)</Route>
                                <DoseSchedule>Mice were primed with 100 μg LPS in 100-μl CFA and boosted in IFA at 2 week intervals.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>GalNAcT-/- mice possess only GM3 and GD3 gangliosides, lacking GD1a, GT1a, GQ1b, and GM1 gangliosides.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>A significant elevation (p&lt;0.005) in serum IgG titres were detected in GalNAcT -/- mice after the 3rd immunization.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>GQ1b ganglioside commercial preparation</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionNonSequenceMolecule>
                                        <ChemicalType>Carbohydrate</ChemicalType>
                                        <Molecule>
                                            <ChEBIId>CHEBI:27515</ChEBIId>
                                        </Molecule>
                                        <SourceOrganismId>7742</SourceOrganismId>
                                    </AccessionNonSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figures 2 and 3B</LocationOfData>
                        <BCellId>17713</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                                <Age>6 - 8 wo</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionNonSequenceMolecule>
                                            <ChemicalType>Carbohydrate</ChemicalType>
                                            <Molecule>
                                                <ChEBIId>CHEBI:27515</ChEBIId>
                                            </Molecule>
                                            <SourceOrganismId>7742</SourceOrganismId>
                                        </AccessionNonSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Ganglioside GQ1b</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                                <Route>Intraperitoneal (i.p.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Mice were primed with 60 μg ovalbumin in alum and then immunized 7-10 days later via the i.p. route with an ovalbumin-liposome formulation containing 100μg ganglioside per mouse. Subsequent immunizations were administered at 2-week intervals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Positive IgG responses were seen after the 2nd and 3rd immunizations, which were exclusively of the IgG3 isotype.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG3</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>GQ1b ganglioside commercial preparation</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionNonSequenceMolecule>
                                        <ChemicalType>Carbohydrate</ChemicalType>
                                        <Molecule>
                                            <ChEBIId>CHEBI:27515</ChEBIId>
                                        </Molecule>
                                        <SourceOrganismId>7742</SourceOrganismId>
                                    </AccessionNonSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

